Results 241 to 250 of about 31,041 (297)

Colchicine and the risk of major adverse cardiovascular events in patients with gout and Type 2 diabetes: A nationwide cohort study

Journal of Internal Medicine, EarlyView.
Abstract Background Type 2 diabetes mellitus (T2DM) and gout are associated with an increased risk of cardiovascular events. Despite the approval for the secondary prevention of cardiovascular diseases by the United States Food and Drug Administration in 2023, evidence regarding the effectiveness of colchicine among T2DM population remains limited ...
Minjeong Jeon, Yongtai Cho, Sungho Bea, Wonkyoung You, Sung Kweon Cho, Seungho Ryu, Yoosoo Chang, Ju‐Young Shin   +7 more
wiley   +1 more source

Outcomes of Carotid Artery Stenting without Embolic Protection in Yemen: A Resource-Constrained Experience. [PDF]

J Neuroendovasc Ther
Al-Athwari A.
europepmc   +1 more source

Incidence and Risk Factors of Peri‐Implantitis Over Time—A Prospective Cohort Study

Journal of Periodontal Research, EarlyView.
Identifying true risk factors requires a longitudinal evaluation to verify the temporality criterion. This study identified periodontitis (stage and grade), lifestyle behaviours (smoking and sleep duration), implant location, and prosthetic factors (restoration type and margin location) as risk factors for peri‐implantitis.
Mario Romandini, Cristina Lima, Diogo Banaco, Rita Azevedo, Mariano Sanz   +4 more
wiley   +1 more source

Persistent Gingival Bleeding Related to Periodontal Disease. [PDF]

Cureus
Iijima Y, Yamada M, Takahashi T, Hino S, Sano M, Sakagami H, Horie N, Kaneko T.   +7 more
europepmc   +1 more source

Decrease of excessive daytime sleepiness after shunt treatment for normal pressure hydrocephalus

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Sleepiness and apathy are often reported in patients with normal pressure hydrocephalus. However, research on outcomes after shunt surgery has mainly focused on the classical triad symptoms, that is, gait, cognition, and bladder dysfunction. This study aimed to describe the effects of shunt treatment on excessive daytime sleepiness and whether ...
Simon Lidén, Anna Lindam, Dan Farahmand, Anne‐Marie Landtblom, Katarina Laurell   +4 more
wiley   +1 more source

Baseline and longitudinal patterns of Non-HDL-C to HDL-C ratio (NHHR) and major adverse cardiovascular events in peripheral artery disease. [PDF]

Sci Rep
Zhang Y, Jing Z, Liu Z, Lai A, Tan G, Yan BP.   +5 more
europepmc   +1 more source

Expected Benefits From Antibacterial Envelope in Different CIED Patient Populations

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Antibacterial envelope has proven to be safe and effective in reducing cardiac implantable electronic device (CIED) infection. Recently, its role in pocket healing process has also started to be studied, showing additional potential benefits for the patients.
David Duncker, Christine Alonso, Mauro Biffi, Francisco Costa, Rim El Bouazzaoui, Panagiota Flevari, Maria Hee Jung Park Frausing, Andreas Goette, Didier Klug, Edward Maclean, Tobias Tönnis, Emilce Trucco, Andrew J. Turley, Jay Wright, Bruno Valente, Matteo Ziacchi   +15 more
wiley   +1 more source

Trends and Outcomes of Anticoagulation for Post‐Operative Atrial Fibrillation After Coronary Artery Bypass Graft

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The benefit of oral anticoagulation (OAC) in patients with new‐onset postoperative atrial fibrillation (POAF) after coronary bypass grafting remains uncertain. The 2023 American Heart Association (AHA) and the American College of Cardiology (ACC) guidelines recommend 60 days of anticoagulation for POAF, whereas management was ...
Daniel S. Cheah, Kathryn Tsai, Krishna Prasad Kurpad, Yousra Khalid, Sanjay S. Mehta   +4 more
wiley   +1 more source

Is it Time to Ditch the DICH (Delayed Intracranial Hemorrhage) Yet? [PDF]

Cureus
Luciano E, Marquez B, Alashari A, Kulvatunyou N.   +3 more
europepmc   +1 more source